BAJAJ BROKING
Hema CIPEF, an affiliate of Capital Group, is selling a 0.9% stake in Mankind Pharma for ₹762.6 crore. The block deal at ₹2,061 per share represents a 2% discount to the market price, following the drug firm's strong financial performance.
Hema CIPEF, an affiliate of the US-based Capital Group, is set to divest a 0.9% stake in Mankind Pharma Ltd through block deals, valued at ₹762.6 crore. This move comes as part of Capital Group's ongoing strategy in the pharmaceutical sector.
The stake sale involves 37 lakh shares of Mankind Pharma at an issue price of ₹2,061 per share, which reflects a 2% discount to the Tuesday closing price of ₹2,102.50 on the NSE. Kotak Securities Ltd and IIFL Securities Ltd are facilitating the transaction as book runners and brokers.
As of March 31, 2024, Capital Group held a 2.22% stake in Mankind Pharma. In December of the previous year, Capital Group had divested a 3.14% stake in the company.
Mankind Pharma reported robust financial results for the fourth quarter ending March 31, 2024. The company recorded a significant 65.1% year-on-year increase in net profit, amounting to ₹471.2 crore compared to ₹285.4 crore in the same period last year. Revenue from operations also saw a notable 19% rise to ₹2,441.1 crore from ₹2,052.7 crore year-on-year.
At the operating level, Mankind Pharma's EBITDA surged by 41.8% to ₹591.1 crore in Q4 of FY24, up from ₹416.7 crore in Q4 of FY23. The EBITDA margin expanded to 24.2% from 20.3% year-on-year, indicating improved operational efficiency.
Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.
This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.
For All Disclaimers Click Here: https://bit.ly/3Tcsfuc
Share this article:
Commodities Market Today | Wti Crude Up 1%, Brent At $75.62, Gold Rises 0.3%
06 Nov, 2024 | 1 Min. read
Share Market Today | Gift Nifty Hints At Flat Start; Consolidation Likely Ahead
06 Nov, 2024 | 4 Min. read
Voltamp Transformers Secures ₹263.3 Cr Order from GETCO
06 Nov, 2024 | 2 Min. read
Gold Rate Today | Gold Rises 0.3% To $2,753.70; Silver Up 0.6% To $32.79
06 Nov, 2024 | 2 Min. read
HZL OFS Opens Today with Floor Price at Rs. 505 Per Share
06 Nov, 2024 | 2 Min. read
Hero MotoCorp to Launch in Europe and UK by H2 2025
06 Nov, 2024 | 2 Min. read
CPI and IIP Data Release Time Shifted to 4 PM
06 Nov, 2024 | 2 Min. read
Berger Paints Q2 Results FY24-25 Highlights, ₹2,774.6 Cr Revenue
05 Nov, 2024 | 2 Min. read
Commodities Market Today
05 Nov, 2024 | 1 Min. read
Share Market Today | Gift Nifty Hints At Flat Market Open, Range-Bound Trend
05 Nov, 2024 | 4 Min. read
Solar Industries Secures ₹399 Crore Defence Export Order
05 Nov, 2024 | 2 Min. read
Gold Rate Today | Gold Dips 0.2% To $2,745, Silver Falls 0.3% To $32.59
05 Nov, 2024 | 2 Min. read
RBI Launches ULI: Transforming Loan Access
August 27, 2024 | 4 Min. read
Textile Sector in India
September 20, 2024 | 5 Min. read
List of IPOs with DRHPs Filed
November 30, 2023 | 3 Min. read
Aditya Birla Group
September 28, 2023 | 10 Min. read
Bajaj Housing Finance Ltd IPO: Things Smart Investors Need to Know
September 05, 2024 | 4 Min. read
Budget Stock Ideas 2024-2025 | Stocks to Buy Today
July 24, 2024 | 4 Min. read
IPO Eligibility Criteria : Full Details
March 15, 2024 | 6 Min. read
What Is the Lock-In Period in IPOs?
October 18, 2023 | 6 Min. read
Godfrey Phillips Announces 2:1 Bonus Shares
September 16, 2024 | 7 Min. read
Jindal Group- A Comprehensive Analysis
September 27, 2024 | 7 Min. read
Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading